
Home / Clinics Supported / Longevity
Patient demand for longevity care is climbing, and in many markets credible clinics have not kept pace. Our team has launched hundreds of clinics, and we help founders open in all 50 states. No medical background is required to own the business; an independent, state-licensed Medical Director directs all clinical care.
Book a Strategy CallAnti-aging has been rebranded as longevity, and patient demand followed: U.S. searches for "longevity clinic" run 10,000 to 100,000 a month (Google Keyword Planner). The clinic that opens now, positioned correctly, can win share that is hard to displace.
The number that matters is demand in your market, and measuring it is step one of our clinic launch consulting. Read the full longevity clinic business opportunity.
The longevity patient isn't looking for the cheapest option. They're looking for the clinic that understands what they're trying to build, and can help them build it.
Google Keyword Planner, U.S., Sep 2025 to Aug 2026, in the ranges Google reports. "Longevity clinic" moved up a range from a year earlier. Local demand varies by market.
The business is built around protocols, not one-time visits, which creates recurring revenue: members tend to stay enrolled across the year and refer the people closest to them.
IV and intramuscular NAD+ protocols, the flagship longevity service. For NAD+ in cognitive care, see Neurological Wellness; as an IV-bar menu tier, IV Therapy & Infusion.
Sermorelin, prescriber-directed and documented, is the defensible peptide adjunct. Neither Epitalon nor MOTS-c is on the 503A bulks list, in an approved drug or under a USP monograph, and both rest on a temporary HHS enforcement discretion policy (October 2026), not a listing or an approval. Status table: Peptide Therapy.
Photobiomodulation sessions delivered in-clinic. Low overhead, recurring session model.
Microneedling with PRP and related skin protocols. For injectables and full med spa services, see Aesthetics.
Lab panels, biological age testing, and functional health tracking that justify protocol continuity and give patients a reason to return.
Monthly and quarterly tiers that bundle protocols, labs, and check-ins into predictable recurring revenue.
Longevity clinics need what generic consulting misses: NAD+ protocols, peptide suppliers vetted against the Bulks List and positioning aimed at premium patients. Budgeting? See what it costs to open a longevity clinic.
Demographics, competitors and search demand, mapped before you commit capital.
Entity structure, state licensing, and Medical Director introduction. An independent, state-licensed Medical Director directs all clinical care.
Pre-negotiated access to NAD+, lawfully compoundable peptide, and red light suppliers at preferred rates. Protocols in place before your first patient.
Brand identity and a launch marketing strategy aimed at premium patients, not bargain hunters. Marketing execution is a separate engagement.
60 days of advisory support after opening: patient flow, marketing and operations.
The protocols are not the differentiator; the clinic identity is, and with ACG the brand is yours. A longevity clinic franchise such as Anderson Longevity Clinic licenses you its brand and charges royalties for the life of the agreement. See the longevity clinic franchise comparison.
A services list. Competes on price. Loses to whoever opens cheaper nearby.
A clear patient identity. Attracts the right patient. Charges a premium. Builds referrals.
The branded clinic survives saturation. The protocol-only clinic doesn't.
The questions founders ask before opening a longevity clinic. Anything else, ask on the strategy call. No pressure, no pitch.
View All FAQs
Talk with Grayson Miller about longevity demand in your market, the services to launch with and what opening takes. No pitch. No obligation.
ACG is a consulting and advisory firm, not a medical practice; an independent, state-licensed Medical Director directs all clinical care. Results are not guarantees of income. Individual outcomes vary. The 60-day target begins from clinic keys received, market and regulatory conditions permitting.
Knowing the rules is the foundation of every clinic we help launch.
You own and run the business. An independent, state-licensed Medical Director makes every clinical, prescribing and treatment decision, structured for your state's Corporate Practice of Medicine laws. We connect you to a vetted network; you retain your own provider.
PRP, peptides, GLP-1 medications and cellular products each carry federal and state rules, and not every product or use is FDA-approved. Exosomes for therapeutic use are not FDA-approved at all, and we steer you away from them. Your menu and marketing are built to hold up to FDA, FTC and state medical board scrutiny.
We show real ranges and never promise an income or a clinical outcome. What you earn depends on your market, your capital and your execution.
Altos Consulting Group is a business consulting and advisory firm, not a medical practice, and does not provide, prescribe or sell any drug, biologic, device or therapy. The FDA has stated there are currently no FDA-approved exosome products for the treatment of any disease; clinic owners are responsible for the compliance of every product, therapy and claim. See the full regulatory notice below.